Genetec Technology Bhd (0104) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Genetec Technology Bhd MYR 0.16, price MYR 0.33, upside -51.5%, quality 28 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range 0.1550 MYR – 3.73 MYR · fair‑value band 0.1300 MYR – 0.1800 MYR · the 0.3300 MYR price screens above the 0.1600 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Follow Genetec Technology Bhd in your weekly email
Every Wednesday you see whether Genetec Technology Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Genetec Technology Berhad, an investment holding company, designs, manufactures, and sells smart automation systems, customized factory automated equipment, and integrated systems in the United States, Europe, the Middle East, Malaysia, Thailand, Mexico, and internationally.
Show more
Genetec Technology Berhad, an investment holding company, designs, manufactures, and sells smart automation systems, customized factory automated equipment, and integrated systems in the United States, Europe, the Middle East, Malaysia, Thailand, Mexico, and internationally. The company offers assembly solutions, including robotic pick and place, auto fastening, screw driving, dosing, plasma treatment, plastic and metal laser welding, laser marking, servo press, high precision cam driven, and buffer system products; material handling products, such as cartesian robot pick and place integration, robotic integration, auto feed system, and linear feeding system products; and testing and inspection products comprising vision inspection, functional and pressure tests, laser distance measurement, and test integration products. It also provides in-house machining centers; precision tooling jigs and fixtures; aluminium profiles; and engineering services, as well as conceptual design, prototype development, and equipment mass replication. The company serves electric vehicle and battery, automotive, computer peripherals, consumer goods, and healthcare industries. The company was incorporated in 1997 and is headquartered in Bandar Baru Bangi, Malaysia.
Stock analysis
Genetec Technology Bhd (0104) currently trades at 0.3300 MYR, while our model-based Fair Value estimate is 0.1600 MYR, 51.5% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 0.2600 MYR per share, and 0 of the 3 models we run sit above the 0.3300 MYR price.
Bear case: the Dividend Discount group reads lowest at 0.1800 MYR, and 3 of the 3 models stay below the price. Evidence for this calculation is low.
Scenario range: 0.1300 MYR (bear) to 0.1800 MYR (bull), the price of 0.3300 MYR sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 28/100 (below-average quality), in the Industrials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Genetec Technology Bhd reported revenue of 125M MYR in FY2026 versus 224M MYR in FY2022, a compound −13.5%/yr. Reported net income was −175M MYR in FY2026.
Key figures
Market cap 256M MYR (≈ $62.7M) · P/S ratio 2.48 · EPS (TTM) −0.1900 MYR · Dividend yield 6.2% · Net margin −139% · Return on equity −40.1% · Return on assets (EBIT) 3.1% · Operating margin −66.2%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades about 47% below its 52-week high and 113% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −49% fair-value upside, at −52%, 0104 screens richer than that median.
Fair Value models
Bear 0.1300 MYRFair Value 0.1600 MYRBull 0.1800 MYR
Price 0.3300 MYR · Upside -51.5%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.11/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−43.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−24.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.2%
Start year 2021 (pandemic). Over 10 years: −0.3% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−0.6% (2021) → −103.9% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 803 stocks
Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score28 · Bottom 25%
Fair Value upside−51.5% · Below median
Profitability
Return on assets−18.9% · Bottom 25%
Net margin (TTM)−140.9% · Bottom 25%
Operating margin (TTM)−66.2% · Bottom 25%
Growth and dividend
Revenue growth−50.3% · Bottom 25%
Dividend yield (TTM)6.2% · Top 25%
Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper
P/B0.21× · Cheapest 25%
P/S (TTM)0.61× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 32
PAST (return on equity)0· sector 28
HEALTH (low debt)100· sector 96
DIVIDEND (yield)100· sector 26
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Genetec Technology Bhd Fair Value". https://www.fairvalue-calculator.com/stock/0104
Frequently asked questions
Is Genetec Technology Bhd (0104) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of 0.1600 MYR versus a price of 0.3300 MYR, about −52% upside (overvalued).
What is the fair value of 0104?
Our model-based fair value for Genetec Technology Bhd is 0.1600 MYR (as of Oct 2, 2026), built from audited fundamentals. The current price: 0.3300 MYR.
What is the quality score of 0104?
Genetec Technology Bhd has a Quality Score of 28/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Genetec Technology Bhd (0104)?
Our model-based price target is the fair value of 0.1600 MYR (as of Oct 2, 2026) from 3 valuation models. Cautious scenario 0.1300 MYR, optimistic scenario 0.1800 MYR. It is a calculation from audited fundamentals, not an analyst target.
What is the Genetec Technology Bhd stock forecast for 2026?
Our models put fair value at 0.1600 MYR, about −52% upside versus a price of 0.3300 MYR (overvalued). Cautious scenario 0.1300 MYR, optimistic scenario 0.1800 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Genetec Technology Bhd (0104)?
Genetec Technology Bhd reported trailing-twelve-month revenue of about 103M MYR (latest available figure, as of Oct 2, 2026).
Does Genetec Technology Bhd pay a dividend?
Genetec Technology Bhd currently shows a dividend yield of about 6.15% relative to its recent price (as of Oct 2, 2026).
What is the intrinsic value of Genetec Technology Bhd (0104)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Genetec Technology Bhd it is 0.1600 MYR per share (as of Oct 2, 2026), against a price of 0.3300 MYR. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is Genetec Technology Bhd stock overvalued or undervalued in 2026?
As of Oct 2, 2026, 0104 trades above its calculated fair value: price 0.3300 MYR, fair value 0.1600 MYR, a gap of about −52% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0104?
No. The price is what the market pays today (0.3300 MYR); the fair value is what the company's own numbers justify (0.1600 MYR). For Genetec Technology Bhd the two are 0.1700 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Genetec Technology Bhd worth?
The market values Genetec Technology Bhd at about 256M MYR (market capitalisation, as of Oct 2, 2026). Per share that is 0.3300 MYR; our models calculate a fair value of 0.1600 MYR per share.
What do the bullish and bearish scenarios say about 0104?
Our models span a range for Genetec Technology Bhd: cautious scenario 0.1300 MYR, base 0.1600 MYR, optimistic 0.1800 MYR per share (as of Oct 2, 2026, price 0.3300 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Genetec Technology Bhd (0104)?
Balance-sheet figures for Genetec Technology Bhd (as of Oct 2, 2026): return on equity −40.1%. They feed the Quality Score of 28/100, which measures business quality independently of the share price.
How far is 0104 from its 52-week high?
Genetec Technology Bhd trades at 0.3300 MYR, about 47% below its 52-week high of 0.6250 MYR and 113% above the low of 0.1550 MYR (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 0.1600 MYR is for.
Which stocks are comparable to Genetec Technology Bhd?
From the same area (Industrials) we also value GE Vernova Inc, SIE, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Genetec Technology Bhd stock attractive at the current price?
The data as of Oct 2, 2026: price 0.3300 MYR, calculated fair value 0.1600 MYR (−52%), Quality Score 28/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 0104 calculated?
We run Genetec Technology Bhd through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.1600 MYR, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Genetec Technology Bhd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Genetec Technology Bhd (0104)?
The closing price on Oct 2, 2026 was 0.3300 MYR. Our model-based fair value is 0.1600 MYR, about −52% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Genetec Technology Bhd right now?
The price sits above even our optimistic bull case (0.1800 MYR). The favourable scenario is already priced in. Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Genetec Technology Bhd
How large is the market capitalisation of Genetec Technology Bhd (0104)?
The market capitalisation of Genetec Technology Bhd is 256M MYR (≈ $62.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Genetec Technology Bhd (0104)?
The price-to-sales ratio of Genetec Technology Bhd is 2.48 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Genetec Technology Bhd (0104)?
Earnings per share at Genetec Technology Bhd are −0.1900 MYR. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Genetec Technology Bhd (0104)?
The dividend yield of Genetec Technology Bhd is 6.2%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Genetec Technology Bhd (0104)?
The net margin of Genetec Technology Bhd is −139% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Genetec Technology Bhd (0104)?
The return on equity (ROE) of Genetec Technology Bhd is −40.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Genetec Technology Bhd (0104)?
On an EBIT basis the return on assets of Genetec Technology Bhd is 3.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Genetec Technology Bhd (0104)?
The operating margin of Genetec Technology Bhd is −66.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Genetec Technology Bhd (0104)?
Revenue at Genetec Technology Bhd is growing −50.3% versus a year earlier (3y avg −24.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Genetec Technology Bhd (0104)?
Earnings per share at Genetec Technology Bhd are growing +53.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Genetec Technology Bhd (0104) generate?
The free cash flow of Genetec Technology Bhd is −113M MYR (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Genetec Technology Bhd (0104) carry?
The net debt of Genetec Technology Bhd is 58.1M MYR (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Genetec Technology Bhd in the live analysis
One click puts Genetec Technology Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
